David A Fullerton Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

10/2022	Simvastatin Inhibits Histologic Changes Associated with Gastroduodenal Reflux in a Murine Model.
1/2021	Statins Inhibit Toll-Like Receptor 4-Mediated Growth of Human Esophageal Adenocarcinoma Cells.
11/2011	Statin therapy attenuates growth and malignant potential of human esophageal adenocarcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Fullerton Research Topics

Disease

16	Ischemia 01/2023 - 05/2008
16	Inflammation (Inflammations) 01/2022 - 08/2007
14	Neoplasms (Cancer) 01/2022 - 03/2010
13	Reperfusion Injury 01/2019 - 06/2008
12	Spinal Cord Ischemia 01/2022 - 01/2011
10	Adenocarcinoma 10/2022 - 03/2010
9	Lung Neoplasms (Lung Cancer) 02/2021 - 02/2012
8	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 01/2008
7	Myocardial Ischemia (Ischemic Heart Diseases) 03/2016 - 08/2002
5	Aortic Valve Disease 01/2023 - 11/2012
5	Hyperplasia 10/2022 - 12/2009
5	Stroke (Strokes) 01/2022 - 05/2013
5	Paraplegia (Spastic Paraplegia) 03/2015 - 01/2011
4	Endotoxemia 05/2023 - 06/2007
4	Infections 01/2022 - 01/2006
4	Barrett Esophagus (Barrett's Esophagus) 01/2021 - 12/2009
4	Adenocarcinoma of Lung 10/2020 - 02/2012
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2023 - 01/2011
3	Infarction (Infarctions) 01/2022 - 12/2011
3	Chronic Obstructive Pulmonary Disease (COPD) 10/2020 - 04/2008
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2018 - 01/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 09/2012
3	Gastroesophageal Reflux (GERD) 03/2010 - 06/2008
2	COVID-19 12/2022 - 01/2022
2	Respiratory Insufficiency (Respiratory Failure) 12/2022 - 05/2022
2	Carcinogenesis 01/2022 - 06/2008
2	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 05/2011
2	Hypertension (High Blood Pressure) 10/2020 - 10/2019
2	Metaplasia 01/2019 - 06/2008
2	Sclerosis 06/2017 - 01/2017
2	Vascular Calcification 11/2015 - 04/2011
2	Neoplasm Metastasis (Metastasis) 09/2012 - 02/2012
2	Atherosclerosis 11/2011 - 12/2010
2	Hemorrhagic Shock 08/2007 - 03/2005
1	Primary Graft Dysfunction 01/2024
1	Sepsis (Septicemia) 01/2023
1	Esophageal Diseases 01/2022

Drug/Important Bio-Agent (IBA)

11	Secretory Phospholipases A2IBA 01/2021 - 12/2009
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2008
8	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 01/2008
8	Toll-Like Receptor 4IBA 01/2022 - 03/2005
7	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2023 - 06/2007
7	Phospholipases (Phospholipase)IBA 04/2013 - 06/2008
5	salicylhydroxamic acid (SHAM)IBA 01/2023 - 01/2011
5	Simvastatin (Zocor)FDA LinkGeneric 10/2022 - 11/2011
5	Erythropoietin FDA Link 12/2018 - 01/2011
5	EnzymesIBA 01/2017 - 06/2008
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2011 - 03/2005
4	Interleukin-6 (Interleukin 6)IBA 05/2023 - 03/2016
4	oxidized low density lipoproteinIBA 01/2017 - 04/2011
4	CytokinesIBA 01/2017 - 05/2008
3	Diazoxide (Hyperstat)FDA Link 01/2023 - 01/2018
3	Nicorandil (SG 75)IBA 01/2023 - 01/2021
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 11/2011
3	Phosphotransferases (Kinase)IBA 01/2021 - 03/2015
3	NF-kappa B (NF-kB)IBA 01/2021 - 05/2008
3	Oxygen (Dioxygen)IBA 05/2015 - 08/2007
3	BiglycanIBA 04/2015 - 11/2012
3	Dexmedetomidine FDA Link 04/2014 - 11/2012
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2023 - 01/2022
2	Potassium Channels (Potassium Channel)IBA 01/2023 - 01/2021
2	Toll-Like Receptor 2IBA 01/2023 - 10/2020
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2021
2	Deoxycholic Acid (Sodium Deoxycholate)IBA 01/2022 - 01/2022
2	CreatinineIBA 01/2022 - 01/2021
2	CollagenIBA 01/2022 - 06/2017
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 12/2012
2	SolutionsIBA 01/2021 - 01/2021
2	Atorvastatin (Lipitor)FDA Link 01/2021 - 11/2011
2	Matrilin ProteinsIBA 01/2020 - 01/2017
2	Neuroprotective AgentsIBA 12/2018 - 01/2018
2	InterleukinsIBA 01/2017 - 05/2008
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2015 - 01/2014
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2015 - 09/2014
2	LipopolysaccharidesIBA 04/2014 - 07/2008
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2014 - 04/2013
2	CalciumIBA 06/2013 - 07/2008
2	Messenger RNA (mRNA)IBA 12/2012 - 11/2012
2	Hematoxylin (Haematoxylon)IBA 11/2012 - 06/2008
2	Group II Phospholipases A2IBA 11/2012 - 09/2012
2	Eosine Yellowish-(YS) (Eosin)IBA 11/2012 - 06/2008
2	AcidsIBA 05/2011 - 04/2010
2	Hemoglobins (Hemoglobin)IBA 04/2009 - 08/2007
1	Bretschneider cardioplegic solutionIBA 01/2024
1	Saline SolutionIBA 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA 01/2023
1	2- phenyl- 4,4,5,5- tetramethylimidazoline- 1- oxyl- 3- oxideIBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2022

Therapy/Procedure

10	Therapeutics 10/2020 - 01/2011
5	Lung Transplantation 05/2022 - 04/2008
4	Transplantation 01/2024 - 09/2014
4	Length of Stay 01/2022 - 01/2020
3	Injections 01/2021 - 08/2002
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2020 - 01/2006
2	Extracorporeal Membrane Oxygenation 12/2022 - 10/2020
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2019 - 10/2013
2	Sternotomy 07/2015 - 01/2006
1	Punctures 01/2023
1	Ligation 01/2023